Issue 45: Pharma Digest

The Digest is for you, the valued members of our pharma community. Receive the latest market movements, breaking pharma news, business-critical whitepapers and content, and updates on our exclusive executive summits. Don’t forget to subscribe using the button above.

Let's get started.

Transforming Real-World Data (RWD) Strategies with AI: Key Insights

As artificial intelligence (AI) continues to revolutionize the healthcare and pharmaceutical industries, it's becoming increasingly important for pharma executives to understand how it can help their RWD strategies.?A recent panel discussion brought together experts from Moderna, Viatris, Pfizer, and Veradigm to explore the intersection of AI and RWD and highlighted its tremendous potential and possible challenges. Read the article here.

Generative AI to transform clinical development

By using AI to optimize drug-development processes, the potential to accelerate the delivery of critical medicines is huge. Our new whitepaper, in collaboration with IBM, explores how AI is redefining clinical development. Explore how industry leaders are harnessing AI to streamline study design, site selection, and more - download the whitepaper here.

#clincaldevelopment #clinicalpharma #drugdevelopment

Driving patient value through innovation and partnership with Claus Zieler

Join Claus Zieler, Chief Commercial Officer at Astellas, as he discusses driving patient value through innovation and partnerships. Don't miss his insights on the pharmaceutical industry's pivotal role and the future of healthcare. Listen here now or tune in on Spotify here.

#PharmaPulse #PharmaceuticalIndustry #Innovation #patientvalue

Top 5 pharma news to watch

1. Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars (Reuters.com, December 5)
2. Novartis' latest attempt to fend off MSN's Entresto generic falls short on appeal (Fierce Pharma, December 5)
3. Novo Nordisk to cut US list prices of two insulin products by more than 70% (Reuters.com, December 5)
4. Janux impresses Wall Street with new prostate cancer drug results (Biopharma Dive, December 3)
5. GSK taps a startup for shot at Alzheimer’s drug (Pharma Voice, December 5)

Event spotlight

?? Join the Future of Pharma at Reuters Events: Pharma 2025! ??

The pharmaceutical industry must balance scientific progress with accessibility and evolving consumer needs. To succeed, we must harness purpose, technology, and data to deliver greater value. Join Pharma 2025 in Barcelona (April 9-11) for candid discussions with over 1000 senior executives from medical affairs, commercial, marketing, digital health, and patient engagement to map the course of your next 12 months.

Hear from industry leaders like:

• Liselotte Hyveled, Chief Patient Officer, Novo Nordisk
• J?rg Schüttrumpf, Chief Scientific Innovation Officer, Grifols
• Ridwaan Jhetam, Senior Vice President: Head of Worldwide Medical Affairs Hematology, Bristol Myers- Squibb
• Ana Cerderia, Vice President, Global Head Commercial, Development Assets, Innovative Medicines Group, Grunenthal
• Chetak Buaria, VP, Global Commercial Operations - Oncology, Merck
• Andreas Gerloff, VP, Global Head of Medical Customer Excellence, Bayer Pharmaceuticals
• Vikram Mohan, Marketing Director, Oncology International, Regeneron
• Yvette Venable, Global Market Acccess Payer Partnerships and Policy, AstraZeneca
• Giorgio Mazzoleni, Head of Global Medical Digital, ViiV Healthcare

Secure your spot before the new year and save €450 off a pharma pass with code "FESTIVE450" by registering before December 6th!

#REpharma

Thanks for reading! If you have any feedback or would like to see something included in our newsletter, get in touch with our team!

EU Team

Daisy Beale

Ziyanda Dludla

Suzy Wang

Emma Haslam

USA Team

Charlotte Bastiaanse

Noah Dixon

Jacob Byerley

Samuel Baddeley

See you next time!